Suchergebnisse - "Dougados, Maxime"

PubPharm (1.143)

91

Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis : Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study

enthalten in: Arthritis & Rheumatology | 2022

von Baraliakos, X. | Deodhar, A. | Dougados, M. | +12

92

Fat mass and response to TNFα blockers in early axial spondyloarthritis : an analysis of the DESIR cohort

enthalten in: Annals of the rheumatic diseases | 2022

von Molto, A. | Tang, S. | Combe, B. | +2

93

Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis : Results From a 3-round Delphi Survey

enthalten in: The Journal of rheumatology | 2021

von Boel, A. | Navarro-Compán, V. | Boonen, A. | +5

94

Association between individual and country-level socioeconomic factors and work participation in spondyloarthritis including psoriatic arthritis: analysis of the ASAS-perSpA study

enthalten in: bioRxiv.org | 2021

von Zhao, S. | Nikiphorou, E. | Boonen, A. | +3

95

How to fill the gap between clinical trials and daily practice in chronic inflammatory rheumatic diseases?

enthalten in: Joint bone spine | 2021

von Dougados, M.

96

Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department

enthalten in: Rheumatology international | 2021

von Portier, E. | Dougados, M. | Moltó, A.

97

Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department

enthalten in: Rheumatology international | 2021

von Portier, E. | Dougados, M. | Moltó, A.

98

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis : a cluster analysis in the worldwide ASAS-PerSpA study

enthalten in: RMD open | 2021

von López-Medina, C. | Chevret, S. | Molto, A. | +27

99

Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials

enthalten in: Rheumatology international | 2021

von Dougados, M. | Kiltz, U. | Kivitz, A. | +6

100

Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials

enthalten in: Rheumatology international | 2021

von Dougados, M. | Kiltz, U. | Kivitz, A. | +6